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ABSTRACT
The Stromelysin-1 gene promoter contains a
palindrome of two Ets-binding sites (EBS) that bind
the p51 and p42 isoforms of the human Ets-
1-transcription factor. A previous study established
that full gene transactivation is associated with a
ternary complex consisting of two p51 bound to
the two EBS on the promoter. p42, only able to
bind one of the two EBS, induces only very weak
activity. Here, we investigate the mechanism by
which the Stromelysin-1 promoter discriminates
between p51 and p42. The differential stoichiometry
of the two Ets-1 isoforms arises from the
Stromelysin-1 EBS palindrome. The ternary complex
requires the presence of two inhibitory domains
flanking the DNA-binding domain and the ability to
form an intramolecular autoinhibition module. Most
importantly, the p51-ternary and the p42-binary
complexes induce DNA curvatures with opposite
orientations. These results establish that differential
DNA bending, via p51 and p42 differential binding,
is correlated with the Stromelysin-1 promoter acti-
vation process.
INTRODUCTION
Ets-1 is the founding member of the E26 transforming
speciﬁc (ETS) family of transcription factors characterized
by a conserved DNA-binding domain (DBD), called the
ETS domain. The DBD recognizes speciﬁc DNA elements
called ETS-binding sites (EBS), that include the consensus
50-GGAA/T-30 core motif present in the promoter of
target genes (1,2). By binding to these elements, Ets-1
activates the transcription of several genes implicated in
various processes such as development, angiogenesis,
tumor invasion and apoptosis (3). However, the mecha-
nism of Ets-1-mediated transcriptional activation is not
completely understood. The current model involves
only interactions with co-activators that induce histone
acetylation and allow contacts with components of the
basal transcription machinery (3,4).
Among the gene promoters requiring Ets-1, the
Stromelysin-1 (matrix metalloproteinase-3 or MMP-3)
promoter is particularly relevant from a biological point
of view. Stromelysin-1 is a matrix metalloproteinase
involved in remodeling the extracellular matrix during
certain physiological and pathological processes (5,6).
Increased coexpression of both Ets-1 and Stromelysin-1
genes has been reported in rheumatoid arthritis (7),
glomerulonephritis (8), angiogenesis (9) and tumor
invasion (10).
Ets-1 binds to the Stromelysin-1 promoter at two head-
to-head GGAA core motifs (i.e. the EBS) separated by
four base pairs, the whole segment being palindromic.
This palindrome is required for basal expression and for
phorbol-12-myristate 13-acetate (PMA)- and interleukin-
1b (IL-1b)-induced expression of the gene (11,12).
Furthermore, our previous work demonstrated that the
binding of Ets-1 to this EBS palindrome is essential for
activating the Stromelysin-1 promoter and inducing pro-
tein expression in the cell (13,14).
The human protein Ets-1 physiologically exists in two
isoforms: p51, the full-length isoform, and p42, a shorter
isoform lacking exon VII due to alternative splicing
(15,16). The lower DNA-binding activity of p51 compared
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p51 allosteric mechanism of autoinhibition (18). In
absence of the cognate DNA, the two inhibitory domains
of p51 (the N-terminal-inhibitory domain, encoded by the
exon VII and the C-terminal inhibitory domain) coopera-
tively interact to form an inhibitory module (19). The
structure of this module, determined by NMR (18) and
X-ray (20), shows that four structurally coupled inhibitory
helices, HI-1, HI-2, H4 and H5, pack intramolecularly
with each other and with the helix H1 of the DBD.
However, this assembly has only limited stability, and
changes between conformational states (18). These char-
acteristics facilitate the structural reorganization of Ets-1
upon DNA binding (21), the optimization of the DNA/
DBD interface involving a shift of the HI-2/H1 region and
the unfolding of HI-1 (18,20). This non-trivial rearrange-
ment is speciﬁc to p51; p42 lacks the N-terminal-inhibitory
domain and therefore the inhibitory module.
Interactions with protein partners that counteract the
autoinhibition mechanism allow p51 to increase its
DNA-binding aﬃnity (22). We established that p51 can
act as its own partner when bound to the palindromic EBS
in the Stromelysin-1 promoter (13). Thus, p51–p51 coop-
erative interaction allows the formation of a ternary p51–
DNA–p51 complex (13). However, p42 only forms a
binary p42–DNA complex despite the presence of two
EBS. This intriguing diﬀerence of binding stoichiometry
between p51 and p42 is of special interest since it corre-
lates with distinct transcriptional activities on the
Stromelysin-1 promoter: p51 induces full transactivation
of the promoter, whereas p42 is much less eﬃcient (13).
Here, we investigated the mechanistic and structural
bases of the diﬀerential DNA-binding stoichiometry of
p51 and p42 on the EBS palindrome, given its crucial
role in the transcriptional control of Stromelysin-1.
The role of the target DNA sequence and of the Ets-
1N-terminal and C-terminal-inhibitory domains was
explored, by mutating both DNA and proteins. The struc-
tural DNA distortions induced upon the complexation
of p51 and p42 were characterized. Overall, the results
suggest a mechanism that accounts for the diﬀerential
DNA-binding stoichiometry of p51 and p42. Further-
more, we propose that Stromelysin-1 promoter activation
is correlated with the isoform-induced orientation of
DNA bending.
MATERIALS AND METHODS
Luciferase-reporter gene
The Stromelysin-1 reporter plasmid pGL3 (Promega) con-
structs containing the wild-type (WT) EBS, or mutant
forms M1, M2, M1M2 and inverted palindrome (IP)
have been previously described (13). The WT+4 reporter
plasmid construct was generated by site-directed mutagen-
esis using the QuickChange Site-directed Mutagenesis
kit (Stratagene) with the WT Stromelysin-1 promoter
construct as a template and the following oligonucleotides
50-ACCAAGACAGGAAGCACGCACTTCCTGGAGA
TTAATC-30 and 50-GATTAATCTCCAGGAAGTGCG
TGCTTCCTGTCTTGGT-30.
Bacterial expression vector constructions
The construction of bacterial expression vectors contain-
ing the cDNA sequences of human Ets-1 isoforms p51
and p42, and of N-terminal deletion mutants N301,
and N331 have been previously described (13). The
cDNAs of the other deletion mutants were obtained by
polymerase chain reaction (PCR) ampliﬁcation using a
unique reverse primer 50-TTCAGGCGCCGATCCCCA
GCAGGCTCTGCAG-30 and the following forward
primers 50-TAGAATTCACATATGAAGGCGGCCGT
CGATCTC-30 for p51C415 and p42C329, 50-AAGT
ATCATATGAAGGGCACCTTCAAGGAC-30 for
p51(301–415), and 50-AAGTATCATATGGGCAGTGG
ACCAATCCAG-30 for Ets-1 DBD. The human Ets-1
p51 or p42 cDNA inserted in a pSG5 vector was used as
a template. The ampliﬁed fragments were digested with
NdeI and SfoI and cloned into a pTYB2 plasmid (T7
Impact System, New England Biolabs) previously digested
by NdeI and SmaI endonucleases.
Eukaryotic expression vector constructions
To construct the eukaryotic expression vectors for Ets-1
p51 and p42, the cDNAs of the two isoforms inserted in
pSG5 plasmids were ampliﬁed by PCR using the following
primers 50-ATAAATAGATCTATGAAGGCGGCCGT
CGATC-30 and 50-ATAAATAGATCTCACTCGTCGG
CATCTGGC-30. The ampliﬁed fragments were digested
with BglII and inserted in a pcDNA3
TM vector
(Invitrogen) previously digested with BamHI. Correct
insertion and orientation were checked by sequencing.
The pcDNA3
TM–p51Y424A construct was generated by
site-directed mutagenesis using the following oligonucleo-
tides 50-CAGAGCCTGCTGGGGGCCACCCCTGAG
GAGC-30 and 50-GCTCCTCAGGGGTGGCCCCCAG
CAGGCTCTG-30 and the QuickChange Site-directed
Mutagenesis kit (Stratagene) with the pcDNA3
TM–p51
construct as a template.
Expression and purification of Ets-1 proteins
Expression and puriﬁcation of Ets-1 proteins were carried
out according to (13), by using the T7 Impact System
(New England Biolabs). Brieﬂy, a culture of Escherichia
coli (ER2566) transformed with the appropriate recombi-
nant plasmid was induced at cell density A595nm=0.7
with isopropyl-b-D-thiogalactopyranoside (IPTG)
(0.3mM ﬁnal) in a Luria-Bertani medium. After 3–4h of
incubation at 308C, the culture was pelleted, washed with
phosphate-buﬀered saline (PBS), and suspended in 10ml
of lysis buﬀer [50mM Tris, pH 8, 150mM NaCl, 1mM
EDTA, 0.1% (v/v) Triton X-100, complete protease
inhibitor mixture (Complete
TM, Roche Molecular
Biochemical)]. Bacteria were lysed with a French press
(1000 pounds/square inch pressure) and lysates were clar-
iﬁed by two successive centrifugations at 20000 g at 48C
(5min and 15min). Each clariﬁed lysate was applied to a
5ml chitin bead column (New England Biolabs), and
columns were washed with 20 volumes of column buﬀer
(lysis buﬀer without protease inhibitor) and rapidly
ﬂushed with 3 volumes of elution buﬀer (column buﬀer
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(DTT). Columns were stored 16h at 48C for peptidic
cleavage and proteins were eluted by 15ml of elution
buﬀer in 1ml fractions. Fractions were subjected to a
10% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS–PAGE) analysis and those containing the
recombinant protein were quick-frozen by immersion in
liquid nitrogen and stored at –808C. Yields were measured
by colorimetry (Bio-Rad protein assay).
Electrophoretic mobility shift assay (EMSA)
Double-stranded oligonucleotides corresponding to the
WT, M1, M2, IP and WT+4 mutants of the
Stromelysin-1 ( 223/ 194) promoter region (Table 1)
were end-labeled using T4 polynucleotide kinase and
[g-
32P]ATP and were subsequently puriﬁed by electro-
phoresis on a 20% polyacrylamide (acrylamide:bisacryla-
mide 19:1, Euromedex) non-denaturing gel in Tris borate
EDTA (TBE) buﬀer (90mM Tris borate, 1mM EDTA).
Recombinant proteins (4 pmol) were incubated with 0.5ng
of each probe in 20 ml of binding reaction buﬀer (20mM
Tris, pH 8, 80mM NaCl, 1mM EDTA, 2mM DTT, 10%
glycerol) for 20min on ice. Complexes formed were
resolved on a 5% or 8% polyacrylamide (acylamide/bisa-
crylamide 29:1, Euromedex) non-denaturing gel in 0.25 
TBE buﬀer at 11.7V cm
 1 at room temperature. Gels
were dried and autoradiographed at  808C.
Several modiﬁcations were done for the circular permu-
tation assay and phasing analysis. EMSA experiments
were calibrated to determine optimal polyacrylamide con-
centration, voltage, temperature and migration time.
Probes corresponded to digestion fragments of circular
permutated or phasing plasmids ampliﬁed by PCR as
described below (see ‘Circular permutation assay’ section
and ‘Phasing analysis’ section). Recombinant proteins
(4pmol) were incubated with 20ng of each probe in
20ml of binding reaction buﬀer containing 1mg of bovine
serum albumin (BSA). Samples were applied to a 5%
polyacrylamide gel (acylamide/bisacrylamide 29:1,
Euromedex) in 0.25  TBE buﬀer at 20.6V cm
 1 at 48C.
Moreover, in all EMSA experiments, p42 gave rise to
small, but detectable amounts of an additional binary
complex which behaved like the main binary complex,
but with higher mobility. This supplementary complex,
already detected in previous studies (13), is most likely
due to a degradation product of p42 that is still able
to bind DNA. We considered this complex to be non-
relevant.
Circular permutation assay
The circular permutated plasmids containing WT or M1
mutant fragment of the Stromelysin-1 ( 223/ 194)
promoter region were constructed using a pBend2 plasmid
(23) digested with SalI and XbaI and inserting the follow-
ing annealed oligonucleotides:
WT, 50-CTAGAACCAAGACAGGAAGCACTTCCTG
GAGATTAG-30 and 50-TCGACTAATCTCCAGGAAG
TGCTTCCTGTCTTGGTT-30;
M1, 50-CTAGAACCAAGACAAAAAGCACTTCCTG
GAGATTAG-30 and 50-TCGACTAATCTCCAGGAAG
TGCTTTTTGTCTTGGTT-30.
The pBend2-WT and -M1 constructs were digested with
MluI, ClaI, SpeI, EcoRV, NruI, KpnI and BamHI. The
resulting 147–155bp fragments (containing the oligonu-
cleotides) were ampliﬁed by PCR and 2mg of each frag-
ment was end-labeled with [g-
32P]ATP (50mCi) using T4
polynucleotide kinase. The probes were puriﬁed using the
QIAquick gel extraction kit (Qiagen) according to the
manufacturer’s instructions and used for EMSA as
described above (see ‘electrophoretic mobility shift assay’).
Migration of both the protein–DNA complexes
(Rbound) and the probes (Rfree) were analyzed using a
PhosphorImage Analyser (Molecular Dynamics) and rel-
ative mobility (Rbound/Rfree) of each complex was calcu-
lated from several independent experiments. The relative
mobility of each complex was normalized to the average
relative mobility of all the complexes and ﬁtted to a
second order polynomial to determine a, b and c coeﬃ-
cients (GraphPad Prism) of the following equation:
Rbound
Rfree
¼ a
D
L
 2
 b
D
L

þ c 1
where L represents the length of the probe and D, the
distance of the center of the two or single EBS (WT or
M1 respectively) from the 50 end of the DNA molecule
(24). The angle, , obtained from the following equation:
CosðÞ¼ a
2c

  1
CosðÞ¼  b
2c

  1
2
gave the bending angle a=1808 –  as described (24).
Phasing analysis
The phasing plasmid constructs were obtained by inserting
into the pBend2-WT plasmid, previously digested with
SalI, the following annealed oligonucleotides containing
A:T tracts: +34, 50-TCGACAAAAACGGGCAAAAAC
GGGCAAAAAG-30 and 50-TCGACTTTTTGCCCGTT
TTTGCCCGTTTTTG-30; +36, 50-TCGACGCAAAAA
CGGGCAAAAACGGGCAAAAACGG-30 and 50-TCG
ACCGTTTTTGCCCGTTTTTGCCCGTTTTTGCG-30;
+38, 50-TCGACACGCAAAAACGGGCAAAAACGG
GCAAAAACGCAG-30 and 50-TCGACTGCGTTTTTG
CCCGTTTTTGCCCGTTTTTGCGTG-30; +40, 50-TC
GACACACGCAAAAACGGGCAAAAACGGGCAAA
AACGCACAG-30 and 50-TCGACTGTGCGTTTTTGC
CCGTTTTTGCCCGTTTTTGCGTGTG-30; +42, 50-T
CGACCGACACGCAAAAACGGGCAAAAACGGGC
AAAAACGCACAGCG-30 and 50-TCGACGCTGTGC
GTTTTTGCCCGTTTTTGCCCGTTTTTGCGTGTCG
G-30; +44, 50TCGACGACGACACGCAAAAACGGGC
AAAAACGGGCAAAAACGCACAGCAGG-30 and
50-TCGACCTGCTGTGCGTTTTTGCCCGTTTTTGC
CCGTTTTTGCGTGTCGTCG-30.
The plasmids pBend2-WT +34, +36, +38, +40, +42,
+44 were digested with EcoRV and the 181–199bp frag-
ments underwent PCR ampliﬁcation. Two micrograms of
Nucleic Acids Research, 2009,Vol.37, No. 13 4343each ampliﬁed fragment were end-labeled with [g-
32P]ATP
(50mCi) using T4 polynucleotide kinase. The probes were
puriﬁed using the QIAquick gel extraction kit (Qiagen)
according to the manufacturer’s instructions and used for
EMSA as described above (see ‘Electrophoretic mobility
shift assay’ section).
Relative mobility of each protein–DNA complex
(Rbound/Rfree) was determined as described above (see
‘Circular permutation assay’ section) from several inde-
pendent experiments and normalized to the average rela-
tive mobility of all the complexes. The normalized relative
mobilities were plotted as a function of linker length,
which is deﬁned as the distance (bp) between the center
of the intrinsic bend (A-tract) and the center of the EBS
palindrome. The best ﬁt to a cosine function (phasing
function) was determined using GraphPad Prism (25).
The DNA bend orientation was determined from the
minima of the phasing functions (26) and expressed as
the angle separating this bend from the intrinsic bend in
a plane perpendicular to the DNA helix axis. The intrinsic
DNA bend is directed toward the minor groove at the
center of the A-tract (27). The helical periodicity was
assumed to be 10.5bp per turn of the DNA helix.
Transient transfection and reporter assay
Human Embryonic Kidney (HEK) 293 cells were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% fetal calf serum in 12-well plates (2ml
per well) to reach 40–60% conﬂuence at time of transfec-
tion. Before transfection, ExGen 500 Transfection
Reagent (2ml per well, Euromedex) was incubated with
250ng of each respective reporter (pGL3) and expression
vector (pcDNA3), and 1.25ng of a control reporter plas-
mid (pRL-null, Promega) for 15min at room temperature
in a volume of 50ml of a 150mM NaCl solution. Cell
medium was changed for 500ml of Opti-modiﬁed Eagle’s
medium (Invitrogen), and DNA-ExGen 500 (Euromedex)
mixture was added. After 6h, DMEM was added (1.5ml
per well). Cells were harvested 48h after transfection with
250ml of cell lysis buﬀer (1% Triton X-100, 25mM gly-
cylglycine, pH 7.8, 15mM MgSO4, 4mM EGTA, 1mM
DTT) per well. Twenty-microliter aliquots of each super-
natant were sequentially tested for ﬁreﬂy and Renilla
luciferases (Dual-Luciferase Reporter Assay System,
Promega) using a Lumat LB 9501 (Berthold). For each
transfection condition, ﬁreﬂy luciferase activity (pGL-3
constructs) was normalized to Renilla luciferase activity
(pRL-null) to correct for variation in the number of trans-
fected cells.
Molecular modeling
The ternary protein–DNA complexes were constructed
by docking two p51N331 proteins on the following
DNA sequences: (i) 50-N6GGAAN4TTCCN6-30 (WT)
(ii) 50-N5GGAAN4+xTTCCN5-30 (WT+x) (iii)
50-N6TTCCN4GGAAN6-30 (IP). These sequences diﬀer
by the number of base pairs composing the spacers N4
or N4+x, with x from 1 to 3, and by the relative orienta-
tion of the two target sites (IP). The models were based on
the crystallographic structure of the binary complex with
p51N331 bound to the 50-N7GGAAN4-30 target DNA
[(28); PDB code 1K79], p51N331 being simply dupli-
cated on the two EBS of diﬀerent sequences by superim-
posing the EBS core motifs.
Calculations of DNA deformation were performed
using the JUMNA program (29) which represents nucleic
acid ﬂexibility using a combination of helicoidal and inter-
nal variables. Solvent damping of electrostatic interactions
was included using a sigmoidal distance-dependent dielec-
tric function and counter-ion screening was dealt with by
reducing total charges on each phosphate group to  0.5e.
Although rather rudimentary, this solvent representation
has proved useful in modeling DNA solution structure
(30,31). The force ﬁeld Parm98 (32) was applied to the
WT sequence in a canonical B-DNA conformation. This
structure was then minimized under graduated, simple
quadratic distance restraints with steps of 1A ˚ , in order
to move the two GGAA-binding sites away from each
other. Analyses of DNA structure were carried out using
CURVES (33).
RESULTS
EBS configuration and binding stoichiometry of p51 and
p42 Ets-1 isoforms
To determine if the conﬁguration of the Stromelysin-1
EBS palindrome (WT, two head-to-head core consensus
motifs separated by four base pairs, Table 1) is required
for diﬀerential binding stoichiometry between both
human isoforms, p51 and p42 (Figure 1A), we used the
EBS variants shown in Table 1. Two mutated sequences
with only one EBS (M1 and M2) were used for monitoring
the binary complexes. We designed two other sequences
containing two EBS in which (i) the orientation of the two
EBS were inverted (IP, two tail-to-tail core consensus
motifs separated by 4bp) and (ii) the spacer length was
increased by 4bp (WT+4), keeping the original orienta-
tion of the EBS (Table 1). EMSA experiments
were performed with these EBS sequences and either
p51 or p42.
As expected (13), no complex could be detected with
the single EBS sequences M1 and M2 and p51, due to
its autoinhibitory module (Figure 1B, lanes 1 and 2).
Indeed, relatively high dissociation constants (Kd) of
 100nM have previously been measured on p51–M1
and p51–M2 complexes using a surface plasmon
Table 1. Wild type (WT) and mutant sequences of the Stromelysin-1
promoter
Name Sequences EBS
topology
WT 50-ACCAAGACAGGAAGCACTTCCTGGAGATTA-30 ! 
a
M1 50-ACCAAGACAAAAAGCACTTCCTGGAGATTA-30   
M2 50-ACCAAGACAGGAAGCACTTTTTGGAGATTA-30 ! 
b
IP 50-ACCAAGAGCTTCCTGCAGGAAGTGAGATTA-30  !
WT+4 50-ACCAAGACAGGAAGCACGCACTTCCTGGAGATTA-30 ! 
a! and   represent the orientation of the EBS.
bX mutated EBS.
4344 Nucleic Acids Research, 2009, Vol. 37,No. 13resonance kinetic assay (13), which also thereby provided
an estimation of EMSA sensitivity for detecting protein/
DNA binding. M1 and M2 formed binary complexes with
the non-autoinhibited p42 (Figure 1C, lanes 1 and 2). p51
and p42 bound to WT (containing two EBS core motifs)
with distinct stoichiometries. The existence of the ternary
complex p51–WT–p51 was indicated by a slow migrating
band of high intensity (Figure 1B, lane 3), reﬂecting a Kd
of  3nM measured when p51 cooperatively bound to the
second EBS (13). This kind of ternary complex cannot be
observed with p42, which was only able to generate a p42–
WT binary complex (Figure 1C, lane 3). In fact, p42
recognizes M1, M2 and WT with the same aﬃnity (Kd
 20nM, unpublished data). When the two EBS motifs
were either inverted (IP) or separated by a spacer of 8bp
(WT + 4), ternary complexes were detected with p42 and,
to a much lesser extent, with p51 (Figure 1B and C, lanes 4
and 5).
Changes in the EBS conﬁguration encountered in the
Stromelysin-1 promoter tended to eliminate the diﬀerences
in binding stoichiometry between p51 and p42 and thus
the discrimination between p51 and p42 Ets-1 isoforms.
EBS configuration and transactivation activities of p51
and p42 Ets-1 isoforms
We then used transfection experiments to determine
whether the Stromelysin-1 promoter containing the WT
variant is able to induce diﬀerential transactivation prop-
erties with p51 and p42, compared to the M1, M2, IP and
WT+4 variants.
As previously shown (13), p51 and p42 induced distinct
levels of promoter activity with WT. In contrast to p42,
p51 fully transactivated the promoter in a synergistic
manner, the promoter activity being more than three
times higher compared to promoter activity induced by
p42 (Figure 1D). Transactivation drastically decreased
with p51 and p42 bound to M1, M2 and IP
(Figure 1D). In contrast, WT+4 recovered substantial
activity with p51 and p42 (Figure 1D), although clearly
lower than the activity obtained with p51 with the WT
promoter conﬁguration.
Only the WT conﬁguration generated distinct levels of
promoter activity in response to p51 and p42, paralleling
the diﬀerential binding stoichiometry described above.
The full transactivation of the Stromelysin-1 promoter
was associated with the ternary complex p51–WT–p51;
we therefore investigated which p51 domains are required
for the formation of this complex.
Role of the inhibitory domains and DBD in the ternary
complex formation
Previous work showed that deleting the N-terminal region
of p51 spanning from amino acids 1–300 does not alter the
binding stoichiometry for the EBS palindrome found in
the Stromelysin-1 promoter (13,34). The p51N301
mutant, which contains the two inhibitory domains in
addition to the DBD, was the shortest Ets-1 protein able
to form a ternary complex with the WT promoter conﬁg-
uration. Thus, we focused on the role of each inhibitory
domain in p51N301 on Ets-1-binding stoichiometry.
We used three mutants that contained the DBD and
(i) the complete C-terminal region (p51N331), (ii) the
complete N-terminal region (p51C415), or (iii) only the
N-terminal-inhibitory domain [p51(301–415)] (Figure 2A).
These C-terminal and N-terminal mutants, submitted to
EMSA, formed binary complexes with M1 and M2
(Figure 2B, C and D, lanes 1 and 2), due to the loss of
their potential to autoinhibit DNA binding. When
assessed on WT, they only formed binary complexes
(Figure 2B, C and D, lane 3). The ternary complex was
however restored with WT+4, whatever the mutant
(Figures 2B, C and D, lane 4).
We then investigated the ability of DBD to form a ter-
nary complex in the absence of any inhibitory domain,
Figure 1. EBS conﬁguration in the Stromelysin-1 promoter: diﬀerential
binding stoichiometry and transactivation properties of p51 and p42
Ets-1 isoforms. (A) Schematic organization of the human Ets-1 p51
and p42 isoforms. DBD, DNA-binding domain; PNTD, pointed
domain; ID, inhibitory domain. (B, C) Gel shift assays. Equal amounts
of p51 (B) or p42 (C) were incubated with M1, M2, WT, IP and
WT+4 variants, as deﬁned in Table 1. Binary (2) and ternary (3)
complexes are indicated. Non-relevant complexes (see ‘Materials and
Methods’ section) are indicated by an asterisk. (D) Transient transfec-
tion assays with reporter plasmids containing WT or variant EBS
deﬁned in Table 1 and either p51 or p42 eukaryotic expression
vector. Luciferase activity was normalized and expressed as relative
luciferase activity (RLU).
Nucleic Acids Research, 2009,Vol.37, No. 13 4345using a p42 deletion mutant lacking the C-terminal region
(p42C328) or possessing only the DBD region
(Figure 3A). Only binary complexes were observed with
M1, M2 and WT (Figure 3B and C, lanes 1, 2 and 3),
while ternary complexes appeared with WT+4
(Figure 3B and C, lane 4).
Therefore, proteins containing the DBD but amputated
of one or both inhibitory regions were unable to generate
ternary complexes with WT. Our hypothesis is that, in
the WT promoter variant, the neighboring DBDs of the
two Ets-1 molecules cause steric hindrances that can be
overcome by structural reorganization in the promoter
sequence or by the inhibitory regions. Next, we examine
the possible structural distortions of the promoter
sequence induced in the binary and ternary complexes
before considering the role of the autoinhibitory module.
DNA bending induced by binding of p51 and p42 Ets-1
isoforms to the WT EBS palindrome
We used circular permutation assays for detecting poten-
tial DNA bending (23). The circular permutated DNA
probes consisted of seven DNA fragments containing
either WT or M1 diﬀerently positioned along the pBend
vector (Figure 4A).
The binary complexes formed by p42 and either WT or
M1 located near the vector center (Figure 4B and C,
probes E and N) migrated at slower rates than those in
which the EBS sites were positioned near the ends
(Figure 4B and C, probes M and B). Analyzing the nor-
malized relative mobilities (24) shows that the DNA mole-
cules noticeably bend in p42–WT or p42–M1 complexes
(Figure 4E), with the value of DNA curvatures being
assessed at around 708 in our experimental conditions
(Table 2).
p51 bound to the WT probes (Figure 4D) showed the
same relative mobility patterns (Figure 4F) as p42
(Figure 4E). Employing speciﬁc migration conditions
(i.e. at low temperature, see ‘Materials and Methods’ sec-
tion) made it possible to detect a p51–WT binary complex
(Figure 4D), previously observed and characterized by
cross-linking experiments (13). This binary complex, not
observed with M1, showed that p51 induced similar DNA
bending intensity in both binary and ternary complexes
(Table 2), the curvature amplitude being estimated
around 708. Thus, the binding of a second molecule of
p51 to the EBS palindrome had no dramatic impact on
the DNA curvature amplitude induced by the ﬁrst
molecule.
Both p42 and p51 induced DNA bending and their cur-
vature amplitudes were comparable across the diﬀerent
types of binary and ternary complexes.
DNA curvature is deﬁned by both amplitude and orien-
tation. Given the above, phasing analyses were performed
to determine the orientation of the DNA curvatures gen-
erated by p51 and p42. A set of DNA probes containing
WT located near to or far from a sequence-directed
A-tract bend (Figure 5A) was used for EMSA in the
Figure 2. Role of both inhibitory domains of p51 in DNA-binding
stoichiometry to the EBS palindrome. (A) Map of the p51 isoform
and p51N331, p51C415 and p51(301–415) deletion mutants. (B,
C, D) Gel shift assays. Equal amounts of p51N331 (B), p51C415
(C), or p51(301–415) (D) were incubated with M1, M2, WT and
WT+4 variants, as deﬁned in Table 1. Binary (2) and ternary (3)
complexes are indicated.
Figure 3. Role of the N- and C-terminal parts of p42 in DNA-binding
stoichiometry to the EBS palindrome. (A) Map of p42 isoform and
p42C328 and DBD deletion mutants. (B, C) Gel shift assays. Equal
amounts of p42C328 (B) or DBD (C) were incubated with M1, M2,
WT and WT+4 variants, as deﬁned in Table 1. Binary (2) and ternary
(3) complexes are indicated.
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and the A-tract varied through one helical turn with 2bp
increments. Two bends in the same phase (in phase) coop-
erate and decrease electrophoretic mobility, while two
bends in opposite phase (out of phase) cancel each other
and enhance electrophoretic mobility.
The mobilities of the free probes vary with two para-
meters, their length and the presence of intrinsically bent
A-tracts; they regularly decreased from lanes 1–6
(Figure 5B and C). These variations were not reproduced
when the probes were bound to p42 or p51 (Figure 5B and
C). Analysis of the normalized relative migrations of the
complexes (Rbound probe/Rfree probe) showed that p42–WT
and p51–WT–p51 followed sinusoidal patterns typical of
DNA bending (Figure 5D). Despite their unusually low
amplitudes, these patterns were faithfully reproduced
across several independent experiments. They are in full
agreement with the results obtained by circular permuta-
tion assays, and, in addition, indicate that p42 and p51
induced DNA curvatures with distinct orientations. The
DNA bend orientations were then determined by calculat-
ing the angle separating the A-tract-directed bend and
the bend induced by protein binding (‘Materials and
Methods’ section). The values found for p42 and p51
(Table 2), separated spatially by about 1808, indicate
that these proteins generate opposite DNA bends.
Replacing the center of each EBS related to bend
orientation showed that p42 causes the DNA to bend
towards the minor groove, i.e. towards the protein–
DNA interface (Figure 5E). Conversely, the DNA curva-
ture induced by p51 ternary complex is directed away
from the protein–DNA interface, compressing the DNA
major groove (major groove bending) (Figure 5E).
The DNA bending observed in p42-WT is in agreement
with the binary complex structures [(28), PDB code 1K79,
(35), PDB codes 2STT and 2STW], which revealed a
noticeable DNA minor groove curvature induced by
p51N331. Conversely, DNA bending observed here
with the p51–WT–p51 complex does not correspond to
its crystallographic counterpart, two p51280–436 pro-
teins bound to WT [(34), PDB code 2NNY]. In this sym-
metric ternary complex, the minor groove curvature
detected for the EBS core motif in the X-ray binary com-
plex disappeared and the EBS palindrome was globally
straight, contrary to our results. However, this X-ray
ternary complex also raises another problem concerning
protein homo-dimerization. In 2NNY, the dimerization of
p51280–436 proteins was ensured by patches of amino
acids belonging to the N-terminal-inhibitory region adja-
cent to the DBD (amino acids 379–382) and the DBD
itself (amino acids 327–335), with the most crucial con-
tacts involving amino acids 332–335 and 379–382. The
C-terminal-inhibitory region was not involved either in
Figure 4. Determination of DNA bending amplitude induced by p51
and p42 Ets-1 isoforms. (A) Schematic representation of DNA probes
used for the circular permutation assays. WT or M1 are symbolized by
an open rectangle in probes A-G that correspond to M, C, S, E, N, K
and B nomenclature according to the restriction sites. Restriction
enzyme sites are given below the probe representations. (B, C, D) Gel
shift assays performed with p42 on WT probe (B), p42 on M1 probe (C)
and p51 on WT probe (D), as described in A. Binary (2) and ternary (3)
complexes are indicated. Non-relevant complexes are indicated by an
asterisk. (E, F) Relative mobility as a function of D/L; D is the number
ofbasepairsseparatingthe 50 endoftheprobeandthe EBScenters(center
ofM1orcenter ofWTpalindrome); Listhe lengthofthe probe,expressed
inbasepairs.Thelinescorrespondtothebestsecond-orderpolynomialﬁt.
In E, open diamond: p42-WT and ﬁlled square: p42-M1. In F, unﬁlled
triangle: p51–WT and ﬁlled square: p51–WT–p51.
Table 2. Amplitude and orientation of DNA bend induced by p51 and p42 Ets-1 isoforms
Protein Site Complex type Circular permutation analysis Phasing analysis
Bend angle (8) R2a
Bend orientation (8) R2b
P42 WT Binary 70 0.99 269 0.98
M1 Binary 66 0.97 ND ND
P51 WT Binary 73 0.99 ND ND
WT Ternary 70 0.94 84 0.99
P51Y424A WT Binary ND ND 259 0.98
aR
2 is the coeﬃcient of determination of the ﬁt to a second order polynomial.
bR
2 is the coeﬃcient of determination of the ﬁt to a cosine function.
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ﬁrst intriguing point is that p42 and p51N331 both con-
tain the key amino acids 332–335 and 379–382; however,
they do not form any observable ternary complexes with
WT (Figures 1C and 2B). We could nevertheless hypoth-
esize that the 331–335 loop adopts a shape conducive to
the protein–protein interface owing to a fold involving the
outermost N-terminal region. For instance, the X-ray
structures of Ets-1 dimers (20), as well as 2NNY, show
that, in this part of the protein, the pairs of amino acids
332–327, 343–323 and 346–321 are hydrogen bonded.
However, the second point that is more diﬃcult to explain
is that 2NNY cannot account for the incapacity of
p51C415 and p51(301–415) to form a ternary complex
(Figure 2C and D). If the N-terminal-inhibitory region
and the DBD were suﬃcient to stabilize the ternary
complex, these mutants should have been able to dimerize
in the presence of WT. Discrepancies between solid-state
and solution data may be due to the complex–complex
contacts generated by the crystal lattice (34). In 2NNY,
the ternary complexes were in fact associated in pairs, the
structural unit forming a hexameric assemblage. This
particular crystal packing mobilized the 308–322 section
of the N-terminal-inhibitory regions and consequently
prohibited any interaction between the N- and C-terminal
domains, as our results suggest. Given that our migration
patterns ruled out any durable complex-complex interac-
tion, we thus hypothesize that lattice packing modiﬁes the
ternary complex structure so that it cannot be directly
extrapolated to interactions that occur in solution.
To further examine the role of the N- and C-terminal
domains in the sharp DNA curvature induced by p51, we
addressed the necessity of a pre-existing inhibitory module
in the interaction process.
Role of the inhibitory module in ternary complex formation
and in Stromelysin-1 promoter transactivation
Tyrosine 424 is crucial for the formation of the p51-inhi-
bitory module (18,20) (Figure 6A). Indeed, a single muta-
tion of this tyrosine to alanine in p51 disrupts DNA-
binding autoinhibition due to the unfolding of the HI-1
helix (20). This mutant, p51Y424A, is thus useful for test-
ing the role of a pre-existing inhibitory module on ternary
complex formation and on Stromelysin-1 transactivation.
Overall, p51Y424A behaves as p42. Binary complexes
were observed with M1 or M2 (Figure 6B, lanes 1 and 2),
conﬁrming the loss of DNA-binding autoinhibition. This
binary complex was also observed with WT (Figure 6B,
lane 3), the ternary complex only being detected with
WT+4 (Figure 6B, lane 4). Using the approach detailed
above to measure DNA bending, we found that the pat-
terns obtained with p51Y424A (Figure 6C and D) exactly
parallel those obtained with p42 (Figure 5B and D). Both
proteins induced the same curvature in terms of both
amplitude and direction (Table 2, Figures 5E and 6E).
Finally, the Stromelysin-1 promoter activity associated
with p51Y424A was similar to activity obtained with
p42 (Figure 6F). Moreover, these results emphasize the
problem posed by the 2NNY X-ray structure that fails
to explain the absence of observable p51Y424A–WT–
p51Y424A ternary complex in our experiments since
this mutant contains all the amino acids belonging to
the X-ray Ets1-Ets1 interface.
Therefore, the inability of p51Y424A to reproduce the
properties of p51 with WT implies that the integrity of the
inhibitory module of p51 is required to form the ternary
complex. The results conﬁrm the correlation between
binding stoichiometry, induced DNA bend orientation
and transactivation of the Stromelysin-1 promoter.
Steric protein hindrances on WT and DNA curvature
To better understand why the binding of two p42 was
prevented with WT and not with IP and WT+4, model-
ing investigations were undertaken. Given the results
described above, we chose to investigate the capacity of
DBD in generating ternary complexes using a very simple
Figure 5. Determination of DNA bend orientation induced by p51 and
p42 Ets-1 isoforms. (A) Schematic representation of DNA probes used
for phasing analysis. The probes contain A-tracts (open rectangle) and
the Stromelysin-1 EBS palindrome (shaded rectangle). They are desig-
nated by linker length, i.e. the number of base pairs separating the
A-tract and the EBS centers, which varied by 2bp increments
(0–10bp), through one helical turn. (B, C) Gel shift assays performed
with p42 (B) or p51 (C) in the presence of the probes described in A.
Binary (2) and ternary (3) complexes are indicated. Non relevant com-
plexes are indicated by an asterisk. (D) Relative mobility averaged from
several independent EMSA experiments as a function of linker length
and ﬁtted to a sinusoidal function (lines). (E) DNA bend directions
induced by p51 and p42 are represented by arrows in a plane perpen-
dicular to the long DNA axis, positioned at the EBS palindrome center.
EBS 1 and 2 are the centers of the two core motifs in the WT EBS
palindrome.
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detected. We focused on the DBD because its structure,
identical across the available X-ray (20,28,34) and
NMR (18,35) structures, is not controversial and widely
accepted. In contrast, the N-terminal region of the 2NNY
ternary complex (34) is likely to suﬀer from crystallo-
graphic artifacts, as explained above. Several structures
of the N-terminal are available but they correspond to
Ets-1/Ets-1 or Pax/Ets-1/DNA complexes (20) and are
not relevant in the context of Ets-1/DNA/Ets-1 interac-
tions. Thus, we constructed models based on the X-ray
structure of the binary complex [(28), PDB code 1K79].
The protein is p51N331. The DNA structures consisted
of 1K79 EBS core motifs bent towards the minor groove
and straight B-canonical spacers. Despite their simplicity,
the models gave a good estimate of the relative position of
the DBD linked to the C-terminal domain and their steric
hindrance.
With the WT conﬁguration, two DBD bind in the two
successive major grooves on the same DNA face and
strongly overlap (Figure 7A). The C-terminal domains
do not participate in the steric hindrances because they
are far from each other. The N-terminal-inhibitory
regions, absent in our model, would increase the area of
the steric hindrance zone, the N-terminal DBD parts being
face-to-face and tightly tangled. It is clear that this ternary
complex cannot exist without drastically distorting the
DNA molecule.
Introducing at least three base pairs in the spacer
(WT+3) suﬃciently increases the distance between the
geometric centers of the two recognition sites to circum-
vent the steric hindrance between the two DBD
(Figure 7B) since two p42 molecules are able to bind to
this type of site (Figure 1C). In this model, the N-terminal
and C-terminal regions, while rather far from each other,
remain face-to-face. These relative positions could allow
for some level of cooperativity between two p51 mole-
cules, leading to small amount of active ternary complexes
and in agreement with the experimental data (Figure 1B
and D). Changing the relative orientation of the two EBS
and keeping the 4bp spacer intact (IP) corresponds to a
conﬁguration that also comfortably supports two proteins
(Figure 7C). The two DBD are now located on opposite
Figure 6. Importance of DNA-binding autoinhibition and DNA bend
orientation for Stromelysin-1 promoter transactivation. (A) Detail of
the structure of the Ets-1 inhibitory module around Tyr 424 (20). (B)
Gel shift assays. p51Y424A was incubated with M1, M2, WT and
WT+4 variants, as deﬁned in Table 1. Binary (2) and ternary (3)
complexes are indicated. (C) Gel shift assays were performed with
p51Y424A in the presence of the diﬀerent probes as described in
Figure 5A. (D) Relative mobility as a function of linker length
expressed in base pairs and ﬁtted to a sinusoidal function. (E) DNA-
bending directions induced by p51Y424A, p42 and p51 are represented
by arrows in a plane perpendicular to the long DNA axis, positioned at
the EBS palindrome center. EBS 1 and 2 are the centers of the two core
motifs in the WT EBS palindrome. (F) Transient transfection assays
with reporter plasmids containing M1, M2, WT and WT+4, deﬁned
in Table 1, and either p51Y424A, p51 or p42 eukaryotic expression
vector. Luciferase activities were normalized and expressed as relative
luciferase activity (RLU).
Figure 7. Model of p51N331–DNA–p51N331 ternary complex.
Models of ternary complex of p51N331 proteins bound to WT (A),
WT+3 (B)o rI P( C). The DBD monomers are in blue (one in
‘ribbon’, one in ‘cartoon’), and the C-terminal regions in red. The
clash zones in A are in cyan. The EBS core motifs are in green for
GG.CC and yellow for AA.TT bases.
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C-terminal regions are not in position to interact.
This disposition allows p42 to form ternary complexes
(Figure 1C). However, the minor, observable amount of
p51–IP–p51 observed in Figure 1B cannot be explained by
the model. Since the related transactivation activity asso-
ciated with p51–IP–p51 was not detectable (Figure 1D),
this ternary complex may diﬀer from the native one.
In any case, further investigations are needed to fully
comprehend the nature of this ternary complex.
We then investigated how the WT spacer reacts to
constraints that push the two EBS core motifs away and
what sort of distortions are needed to remove the steric
hindrances between two DBD. This strategy was success-
fully used to account for the DNA deformations induced
by the TATA box-binding protein (30).
The progressive distance constraints applied between
the two EBS geometrical centers moved away from the
EBS, generating an under-twisting and a major groove
curvature on the spacer (Table 3). Systematic dockings
of two p51N331 proteins extracted from 1K79 on
these constrained DNA models showed that a total
under-twisting of around 208 associated with a major
groove curvature of 428 were the minimal changes
required to circumvent DBD clashes (Table 3). Despite
of the reductionism of this approach, the predicted
major groove curvature perfectly matches the bending
direction inferred from the experimental data (Figure 6E).
These theoretical investigations completely corroborate
the experimental results. They help understand why
both IP and WT+4 are able to form ternary complexes
with p51 and p42 (Figure 1B and C). The fact that, in
contrast to IP, WT+4 seemed able to accommodate
an interface between two neighboring proteins could
account for Stromelysin-1 transactivations, which were
substantial with WT+4 but negligible with IP
(Figure 1D). Concerning the curvature, its cost, around
15kcal mol
 1 for a bending magnitude of 428 (Table 3), is
as low or lower than the lowest deformation energies cal-
culated on DNA extracted from 71 X-ray complexes using
the same modeling program (36). This modest energetic
cost should be easily compensated by the gain resulting
from the homo-dimerization of the two neighboring
proteins.
The nature of the intermolecular protein-protein inter-
face cannot be deduced from our investigations and
requires further experiments in conjunction with sophisti-
cated modeling. The extended conformation of the
N-terminal-inhibitory region observed in the X-ray ter-
nary complex appears unrelated to the assembly mecha-
nism (34). Nevertheless, active participation of this
N-terminal-inhibitory region seems more than likely.
Indeed,
15N relaxation and hydrogen exchange NMR
measurements (18) demonstrated that the inhibitory
module consists of a stable scaﬀold made up of the H1,
H4 and H5 helices and a mobile N-terminal-inhibitory
region subject to conformational equilibria. The binding
to DNA is accompanied by drastic changes in the inhib-
itory module. Without completely obliterating the inhibi-
tory module folding, the N-terminal-inhibitory domain
unpacks through the unfolding of HI-1, inducing a
global sliding motion that results in the optimal ﬁt
between H1 and the DNA (18,20). Given that the ternary
complex requires the amino acid residues 333 and 334
(34) close to H1, and a complete, intact and functional-
inhibitory module, this kind of N-terminal-inhibitory
domain rearrangement guided by the C-terminal region
acting as a scaﬀold, is a good candidate for overriding
the autoinhibition mechanism and, at the same time,
mediating the p51–p51 interface within the ternary
complex.
DISCUSSION AND CONCLUSION
The main aim of this work was to better understand the
diﬀerential DNA-binding stoichiometry of the two human
Ets-1 isoforms p51 and p42 on the EBS palindrome found
in the Stromelysin-1 promoter. Indeed, the formation of a
ternary complex with p51 and a binary complex with p42
allows for distinctive controls of Stromelysin-1 promoter
activity (13), the full transactivation being associated
with p51.
We ﬁrst summarize the key results presented in this
work. The conﬁguration of the Stromelysin-1 EBS palin-
drome is crucial for generating either ternary complexes
with p51 or binary complexes with p42. Changes in the
orientation of the two EBS core motifs or in spacer length
cancel the diﬀerences between the two Ets-1 isoforms.
Indeed, these types of EBS variants form ternary com-
plexes regardless of the Ets-1 isoform, but do not result
in eﬃcient transactivation. Operational ternary complexes
require both the N-terminal and C-terminal-inhibitory
domains that also require a complete, intact and func-
tional-inhibitory module. Deleting one or both inhibitory
domains or preventing the formation of the inhibitory
module, only generated binary complexes. This implies
that the two inhibitory regions of Ets-1 are intimately,
structurally as well as functionally, coupled to binding
to the Stromelysin-1 EBS palindrome. Lastly, the func-
tional ternary complex induces noticeable DNA major
groove curvature, whereas the binary complex bends the
DNA in the opposite direction.
These experimental results associated with modeling
investigations made it possible to reveal the mechanism
Table 3. Spacer elongation in WT restrained simulations
d
a (A ˚ ) E
b
(Kcal/mol)
Ic
c (8)T w av
d(8) Protein–protein
steric clashes
00 5 3 7 + +
2.5 4 22 34 +
4.5 15 42 30  0
7.5 37 67 23 –
8.5 44 82 20 –
ad: increase of the distance separating two EBS core motifs in refer-
ence to the starting structure.
bE: diﬀerence between total energies of constained and starting
structures.
cIc: curvative intensity.
dTwav: average twist of the 4bp spacer.
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complexes on the WT EBS palindrome (Figure 8). Our
simulations showed that the formation of a binary com-
plex prohibited the binding of a second protein because of
severe clashes between two neighboring DBD, aggravated
by the N-terminal regions. Inverting the respective orien-
tation of the two EBS, increasing the spacer length
or generating a curvature towards the major groove on
the EBS palindrome center avoided the DBD steric hin-
drance, in agreement with the experimental results.
Furthermore, our experimental data demonstrated that
the cooperative binding of a second p51 on the EBS
palindrome occurred via the simultaneous creation of a
major groove DNA curvature and a p51–p51 interaction.
Most likely, the intermolecular protein-protein interface
corresponds to drastic structural rearrangements of the
inhibitory module primarily implicating the N-terminal
inhibitory domains, mimicking and amplifying the dis-
placement detected in the formation of the binary complex
(18). The strict prerequisite of the presence of two, inter-
acting C- and N-terminal inhibitory domains explains why
p42, lacking the N-terminal inhibitory domain, does not
form a ternary complex.
In addition, our results strongly suggest that the
diﬀerent capacities of p51 and p42 for activating the
Stromelysin-1 promoter were associated with the induced
DNA bending. p51 induces a bend directed away from the
protein–DNA interface and fully transactivates the
Stromelysin-1 promoter, while p42 generates an opposite
bend and activates the promoter only weakly. The p42-
-induced DNA curvature detected in this work has pre-
viously been established at the molecular level (28,35).
Precise characterization of p51–induced DNA curvature
requires further investigations using techniques speciﬁcally
dedicated to bending measurements. However, the global
coherency of our results, together with their reproducibil-
ity, indicates that p51 and p42 produce diﬀerent DNA
distortions, most likely related to the curvature direction.
This relationship between DNA bending and transcrip-
tion activation has only been reported for Thyroid
Receptor (TR) (37) and the Sox2 (38) systems. However,
DNA bending is associated with a large number of eukar-
yotic-transcription factors (39,40). In particular, many
pairs of homo- or heterodimers induce DNA curvatures
of opposite orientation (Fos-Jun/Jun-Jun (25), Myc-Myc/
Max-Max (41), and TR-TR/TR-Retinoid X receptor
dimers (42)). In addition, we found other similar palindro-
mic EBS (i.e. two core motifs separated by 4 base pairs) in
various promoter data banks (data not shown). We
recently showed that Ets-1 behaves identically with the
EBS palindromes of the human p53 and Stromelysin-1
promoters, in terms of both cooperative binding and tran-
scriptional transactivation (43). Taken together, these
observations suggest that the mechanism revealed in
this study could be a common system used to speciﬁcally
activate a repertoire of various promoters. Hence, charac-
terizing induced DNA bending should be a prerequisite to
a complete description and understanding of the subtle
structural dialog between DNA and transcription factors
that guarantees the ﬁne tuning of transcription regulation.
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